结论化疗加放疗能明显提高患者的生存率，降低远处转移率。
Conclusion Radiotherapy and chemotherapy concurrently can obviously increase the survival rate and decrease the rate of the distant metastasis.
肿瘤复发率较高，远处转移率较低，生物学行为较长骨骨肉瘤为好。
The recurrence rate of the tumor was relatively high and the metastasis rate to lung was low. It seems that the tumor had good prognosis than osteosarcoma of long bone.
结论鼻咽癌颈部淋巴结转移切取活检可增加其远处转移率，降低生存率。
Conclusion Cervical incisional biopsy increases distant metastatic rate and decreased survival rate for NPC.
放疗联合胸腺肽治疗能够明显提高鼻咽癌患者的生存率，降低远处转移率。
The combined radiotherapy with thymic peptide can highly improve the survival rate of patients with nasopharyngeal carcinoma and lower its distant metastasis rate.
术后适当地给予2个疗程化疗或局部放疗可能有助于降低局部复发率及远处转移率；
The local recurrent rate and distant metastasis might be reduced by 2 courses of chemotherapy or radiotherapy post-operatively.
术后局部复发和远处转移的精确诊断被公认为是个体化治疗以提高生存率的关键。
An accurate diagnosis of postoperative local recurrence and distant metastasis is crucial for prescribing optimal individualized management and thus elevating the survival rate.
乳腺癌的发病率逐年上升，远处转移是导致患者不良预后的主要原因。
The incidence of breast cancer is rising year by year, distant metastasis is the main reason leading to poor prognosis.
结论放化疗综合治疗N2、N3期鼻咽癌有助于提高短、中期生存率，减少局部复发和远处转移。
Conclusion Radiotherapy with chemotherapy can increase the survival rates and decrease the distant metasis in patients with N2, N3 stage nasopharyngeal carcinoma.
全部患者手术部位癌细胞无远处转移，5年生存率75%。
No distant metastasis was found. The overall 5-year survival rate was 75%.
放、化疗作为骨外骨肉瘤的辅助治疗方法，在提高肿瘤的切除率和减少局部复发和远处转移等方面有帮助。
Radiotherpy and chemotherapy play an adjuvant role in the treatment of EOS, improve the resection rate and reduce the recurrence and metastasis.
随访结果局部复发率1.15 %，无远处转移，无死亡病例。
The local recurrence rate was 1.15% as yet and with no metastasis or dead.
VEGF表达阳性率在发生淋巴结转移、远处转移病人明显高于无转移者（P均<0.05）。
VEGF expression was more frequent in lymph node(P<0.05) and hematogenous(P<0.05) metastatic tumors than in non-metastatic tumors.
回顾性分析两组患者的局部复发和远处转移例数以及2年生存率。
Two groups received the same adjuvant postoperative chemotherapy scheme. 2-year survival, local recurrence and distant metastasis were analyzed.
免疫组化研究对于判断涎腺导管癌早期局部复发、远处转移和生存率有所帮助。
Immunohistochemical study was linked to the early local disease recurrence, distant disease metastasis and survival rates.
随访内容包括患者一年、三年、五年的生存率、局部复发、远处转移、美容效果等。
The follow-up including 1,3,5 years survival rates, local recurrence, distant metastasis and cosmetic effect.
虽然各种诊治措施不断进展，但是甲状腺癌的远期生存率仍然没有得到明显的提高，肿瘤细胞的侵袭和远处转移是其治疗失败的主要原因。
Despite recent advancements in diagnosis and treatment, the long-term survival rate has undergone little improvement in the recent years, which is attributed mainly to tumor invasion and metastasis.
虽然各种诊治措施不断进展，但是甲状腺癌的远期生存率仍然没有得到明显的提高，肿瘤细胞的侵袭和远处转移是其治疗失败的主要原因。
Despite recent advancements in diagnosis and treatment, the long-term survival rate has undergone little improvement in the recent years, which is attributed mainly to tumor invasion and metastasis.
应用推荐